Quarterlytics / Sectors / Healthcare
Sector
Biotechnology · Medical - Devices · Drug Manufacturers - Specialty & Generic · more

Healthcare

861 companies across 9 industries — from early-stage micro-caps to established names the street already knows.

861companies 9industries 58pages
Companies covered 861
Industries 9
Largest industry Biotechnology
Latest filing
Coverage Updated weekly
Browse by industry View all industries →
Exchange Sort
Showing 15 of 861 companies Page 39 of 58
MAZE NASDAQ · 125 emp.

Maze Therapeutics, Inc.

Maze Therapeutics, Inc., a clinical stage biopharmaceutical company, develops small molecule precision medicines for the treatment of renal, cardiovascular, ...

Biotechnology
CRBU NASDAQ · 147 emp.

Caribou Biosciences, Inc.

Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatmen...

Biotechnology
CCCC NASDAQ · 110 emp.

C4 Therapeutics, Inc.

C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatmen...

Biotechnology
CHRN NASDAQ · 55 emp.

Ekso Bionics Holdings, Inc. Common Stock

Ekso Bionics Holdings, Inc. engages in the provision of design, development, and sale of exoskeleton technology that currently has applications in healthcare...

Medical - Devices
DMRA NASDAQ · 7 emp.

Galecto, Inc.

Galecto, Inc. is a clinical-stage biotechnology company, which engages in developing novel small molecule therapeutics that are designed to target the biolog...

Biotechnology
GNLX NASDAQ · 24 emp.

Genelux Corporation

Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing next-generation oncolytic viral immunotherapies for patients suffering...

Biotechnology
LYEL NASDAQ · 300 emp.

Lyell Immunopharma, Inc.

Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapi...

Biotechnology
LXEO NASDAQ · 75 emp.

Lexeo Therapeutics, Inc. Common Stock

Lexeo Therapeutics, Inc. operates as a clinical-stage genetic medicine company that focuses on hereditary and acquired diseases. The company develops LX2006,...

Biotechnology
VOR NASDAQ · 159 emp.

Vor Biopharma Inc.

Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an e...

Biotechnology
MOBI NASDAQ · 167 emp.

Mobia Medical, Inc. Common Stock

Mobia Medical, Inc. operates as a commercial-stage medical device company. It engages in developing solutions for stroke recovery survivors with motor impair...

Medical - Devices
GANX NASDAQ · 23 emp.

Gain Therapeutics, Inc.

Gain Therapeutics, Inc., a biotechnology company, engages in developing various therapies to treat diseases caused by protein misfolding. It focuses on rare ...

Biotechnology
TLSA NASDAQ · 9 emp.

Tiziana Life Sciences Ltd

Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology....

AKTS NASDAQ · 79 emp.

Aktis Oncology, Inc.

Aktis Oncology, Inc. operates as a clinical-stage oncology company that engages in the development of targeted radiopharmaceutical therapies for cancer treat...

EPRX NASDAQ · 33 emp.

Eupraxia Pharmaceuticals Inc.

Eupraxia Pharmaceuticals Inc., a clinical stage biotechnology company, engages in the discovery, development, and marketing of technologies in the biotechnol...

Biotechnology
MGTX NASDAQ · 375 emp.

MeiraGTx Holdings plc

MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops vari...

1 38 39 40 58
Healthcare coverage

The whole sector,
in one read.

We publish original research across all healthcare companies — profiles, earnings reports and news on the small- and mid-caps the market overlooks. 861 companies, permanently indexed. Free to read.

Browse all companies
Editorial photograph